Polymorphism rs4934 of SERPINA3 and sporadic intracranial aneurysms in the chinese population

Cerebrovascular Diseases

Volumn 29, Issue 1, 2009, Pages 68-72

  Liu, Wei ^a   Zhu, Yufang ^b   Ge, Mingxu ^c   Pang, Qi ^a   Yu, Yanbing ^d  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Tumor Hospital   (China)

^c Department of Neurosurgery   (China)

^d CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Genetics; Intracranial aneurysm; Polymorphism; SERPINA3

Indexed keywords

SERINE PROTEINASE INHIBITOR;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; INTRACRANIAL ANEURYSM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERPINA 3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACRANIAL ANEURYSM; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; SERPINS;

EID: 70449517165     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000256649     Document Type: Article

References (31)

1. Peters DG, Kassam AB, Feingold E, Heidrich-O'Hare E, Yonas H, Ferrell RE, Brufsky A: Molecular anatomy of an intracranial aneurysm: coordinated expression of genes involved in wound healing and tissue remodeling. Stroke 2001; 32: 1036-1042.
2. Katati MJ, Santiago-Ramajo S, Perez-Garcia M, Meersmans-Sanchez Jofre M, Vilar-Lopez R, Coin-Mejias MA, Caracuel-Romero A, Arjona-Moron V: Description of quality of life and its predictors in patients with aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis 2007; 24: 66-73.
3. Hosomi N, Naya T, Ohkita H, Mukai M, Nakamura T, Ueno M, Dobashi H, Murao K, Masugata H, Miki T, Kohno M, Kobayashi S, Koziol JA: Predictors of intracerebral hemorrhage severity and its outcome in Japanese stroke patients. Cerebrovasc Dis 2009; 27: 67-74.
4. Rinkel GJ, Djibuti M, Algra A, van Gijn J: Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998; 29: 251-256.
5. Huang J, Van Gelder JM: The probability of sudden death from rupture of intracranial aneurysms: a meta-analysis. Neurosurgery 2002; 51: 1101-1105, discussion 1105-1107.
6. Mostaza JM, Martin-Jadraque R, Vicente I, San Martin MA, Lahoz C: Patients at high risk of cerebrovascular disease: the REACH study. Cerebrovasc Dis 2009; 27(suppl 1):77-81.
7. Rother J, Alberts MJ, Touze E, Mas JL, Hill MD, Michel P, Bhatt DL, Aichner FT, Goto S, Matsumoto M, Ohman EM, Okada Y, Uchiyama S, D'Agostino R, Hirsch AT, Wilson PW, Steg PG: Risk factor profile and management of cerebrovascular patients in the reach registry. Cerebrovasc Dis 2008; 25: 366-374.
8. Feigin VL, Rinkel GJ, Lawes CM, Algra A, Bennett DA, van Gijn J, Anderson CS: Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005; 36: 2773-2780.
9. Wiedow O, Meyer-Hoffert U: Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Intern Med 2005; 257: 319-328.
10. Peplow PV: Glycosaminoglycan: a candidate to stimulate the repair of chronic wounds. Thromb Haemost 2005; 94: 4-16.
11. Steppich BA, Seitz I, Busch G, Stein A, Ott I: Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases. Thromb Haemost 2008; 100: 1068-1075.
12. Hashimoto T, Meng H, Young WL: Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol Res 2006; 28: 372-380.
13. MacIvor DM, Shapiro SD, Pham CT, Belaaouaj A, Abraham SN, Ley TJ: Normal neutrophil function in cathepsin G-deficient mice. Blood 1999; 94: 4282-4293.
14. Shimoda N, Fukazawa N, Nonomura K, Fairchild RL: Cathepsin G is required for sustained inflammation and tissue injury after reperfusion of ischemic kidneys. Am J Pathol 2007; 170: 930-940.
15. Kamboh MI, Minster RL, Kenney M, Ozturk A, Desai PP, Kammerer CM, DeKosky ST: Alpha-1-antichymotrypsin (act or serpina3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease. Neurobiol Aging 2006; 27: 1435-1439.
16. Obach V, Revilla M, Vila N, Cervera AA, Chamorro AA: Alpha(1)- antichymotrypsin polymorphism: a risk factor for hemorrhagic stroke in normotensive subjects. Stroke 2001; 32: 2588-2591.
17. Vila N, Obach V, Revilla M, Oliva R, Chamorro A: Alpha(1)- antichymotrypsin gene polymorphism in patients with stroke. Stroke 2000; 31: 2103-2105.
18. Pera J, Slowik A, Dziedzic T, Szczudlik A: Serpina3 polymorphism is not associated with primary intracerebral hemorrhage in a polish population. Stroke 2006; 37: 906-907.
19. Dardiotis E, Hadjigeorgiou GM, Dardioti M, Scarmeas N, Paterakis K, Aggelakis K, Komnos A, Tasiou A, Xiromerisiou G, Gabranis I, Zintzaras E, Papadimitriou A, Karantanas A: Alpha-1 antichymotrypsin gene signal peptide a/t polymorphism and primary intracerebral hemorrhage. Eur Neurol 2008; 59: 307-314.
20. Klimkowicz A, Slowik A, Dziedzic T, Polczyk R, Szczudlik A: Post-stroke dementia is associated with alpha(1)-antichymotrypsin polymorphism. J Neurol Sci 2005; 234: 31-36.
21. Slowik A, Borratynska A, Turaj W, Pera J, Dziedzic T, Figlewicz DA, Betlej M, Krzyszkowski T, Czepko R, Szczudlik A: Alpha1-antichymotrypsin gene (serpina3) a/t polymorphism as a risk factor for aneurysmal subarachnoid hemorrhage. Stroke 2005; 36: 737-740.
22. Krischek B, Akagawa H, Tajima A, Narita A, Kasuya H, Hori T, Inoue I: The alanine/threonine polymorphism of the alpha-1-antichymotrypsin (serpina3) gene and ruptured intracranial aneurysms in the Japanese population. Cerebrovasc Dis 2007; 23: 46-49.
23. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
24. Zhang B, Fugleholm K, Day LB, Ye S, Weller RO, Day IN: Molecular pathogenesis of subarachnoid haemorrhage. Int J Biochem Cell Biol 2003; 35: 1341-1360.
25. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST: Apoe * 4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nat Genet 1995; 10: 486-488.
26. Yoshizawa T, Yamakawa-Kobayashi K, Hamaguchi H, Shoji S: Alpha1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease. J Neurol Sci 1997; 152: 136-139.
27. International Hap Map Consortium: A haplotype map of the human genome. Nature 2005; 437: 1299-1320.
28. Wang YC, Liu TY, Liu HC, Chi CW, Sim CB, Tsai SJ, Hong CJ: No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Chinese. Neuropsychobiology 1999; 40: 67-70.
29. Wang X, DeKosky ST, Ikonomovic MD, Kamboh MI: Distribution of plasma alpha 1-antichymotrypsin levels in Alzheimer disease patients and controls and their genetic controls. Neurobiol Aging 2002; 23: 377-382.
30. McGeer PL, McGeer EG: Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol 2001; 58: 1790-1792.
31. McIlroy SP, Vahidassr MD, Savage DA, Lloyd F, Patterson CC, Lawson JT, Passmore AP: Association of serum AACT levels and AACT signal polymorphism with late-onset Alzheimer's disease in Northern Ireland. Int J Geriatr Psychiatry 2000; 15: 260-266.